Rachel Katzenellenbogen named co-leader of CPC research program at IU Simon Comprehensive Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Rachel Katzenellenbogen was named a co-leader of the Cancer Prevention and Control research program at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center. 

She serves along with Susan Rawl and Todd Skaar.

A member of the program since 2018, Katzenellenbogen is the chief of the Division of Adolescent Medicine in the Department of Pediatrics, associate professor of pediatrics and of microbiology and immunology, and the Richard E. and Pauline P. Klingler Scholar in Pediatrics at IU School of Medicine. She is also the Chuck and Tina Pagano Scholar at the cancer center.

Katzenellenbogen’s cancer research focuses on the fundamental way human papillomavirus drives cancer development and progression, how that drive is common to all cancers or is unique to this infection-associated cancer, and identifying ways to detect and disrupt these pathways to intervene early in treatment.

Before joining IU, Katzenellenbogen was an associate professor of pediatrics at the University of Washington and Seattle Children’s Research Institute. 

Table of Contents

YOU MAY BE INTERESTED IN

George F. Tidmarsh has resigned from his job as director of the FDA Center for Drug Evaluation and Research in the aftermath of a lawsuit by a former associate and a probe into what an HHS spokesperson described as “serious concerns about his personal conduct.”
Research has shown that delivering tumor profiling results to cancer patients prior to initiation of treatment and connecting patients harboring an actionable oncogenic mutation with the right targeted therapy can deliver superior patient outcomes. To fulfill this promise of precision medicine, we need to ensure more targeted therapies are available to patients who need them. Fortunately, this work is well underway. xxx:more

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login